Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07497737

OMT for Adhesive Capsulitis

Osteopathic Manipulative Treatment as an Adjunct Therapy for Adhesive Capsulitis

Status
Not Yet Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
University Hospitals Cleveland Medical Center · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn if Osteopathic Manipulative Treatment (OMT) is an effective addition to treatment of adhesive capsulitis. OMT is a non-invasive treatment in which a doctor gently moves and stretches muscles, joints, and tissues manually. Adhesive capsulitis is more commonly known as "frozen shoulder" and describes a shoulder that becomes stiff, painful, and limited in its motion due to some structural change in the joint. The main questions it aims to answer are: Is recovery faster when OMT is added to regular treatment? Are patients that underwent OMT more satisfied with their treatment? Researchers will compare patients who underwent OMT to patients who did not to see if OMT is an effective additional treatment for frozen shoulder. Participants will: * Be assigned to one of the four experimental groups * Visit clinic and/or physical therapy to undergo the treatments associated with their group: 1. standard course of prescribed physical therapy 2. standard course of prescribed physical therapy and an injection of an anti-inflammatory and anesthetics in the shoulder 3. standard course of prescribed physical therapy and (up to) 4 OMT sessions 4. standard course of prescribed physical therapy, an injection of an anti-inflammatory and anesthetics in the shoulder, and (up to) 4 OMT sessions. * Visit clinic 1 month, 3 months, 6 months, and 1 year after treatment is complete * Complete a survey about how satisfied they are with their treatment 1 month, 3 months, 6 months, and 1 year after it is complete

Conditions

Interventions

TypeNameDescription
DRUGIntra-articular InjectionIntra-articular injection consisting of 80 mg of methylprednisolone acetate, 2 mL of lidocaine (1%), and 4 mL of ropivacaine (0.5%)
OTHEROsteopathic Manipulative Therapy (OMT)Non-invasive, manual manipulation of the shoulder joint and its surrounding muscles and tissues

Timeline

Start date
2026-04-01
Primary completion
2027-04-01
Completion
2028-05-01
First posted
2026-03-27
Last updated
2026-04-06

Locations

3 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT07497737. Inclusion in this directory is not an endorsement.